Exciting Collaboration in Oral Health Innovation
Sigrid Therapeutics, a Swedish science-driven company, is making waves in the consumer health sector with a keen focus on metabolic health. The firm is most recognized for its clinically proven products, Carb Fence and Glucose Stabiliser, designed to aid in appetite control and blood sugar regulation, respectively.
Strategic Partnership to Expand SiPore® Technology
Recently, Sigrid announced an exclusive global licensing and research collaboration with a prominent multinational consumer health enterprise. This partnership aims to utilize Sigrid's SiPore® technology platform to innovate in consumer oral health, paving the way for novel product formulations.
Potential of SiPore® in Oral Health
Under this collaboration, Sigrid will incorporate the SiPore® platform into new oral health solutions aimed at preventing plaque and dental caries. This non-systemic material technology utilizes specially engineered porous silica particles that mechanically bind and eliminate harmful proteins and enzymes in the mouth.
Commercialization and Financial Benefits
The terms of this licensing agreement include an upfront payment, milestone payments based on development and sales, and long-term royalties on net sales. This arrangement supports Sigrid’s drive to realize additional value from the SiPore® platform while maintaining a capital-efficient and non-dilutive strategy.
Addressing Global Oral Health Challenges
With oral diseases being the most prevalent health issues globally, impacting around 3.5 billion individuals, the oral health market presents significant opportunities. The toothpaste market is estimated at USD 19 billion and is projected to reach USD 28 billion as preventive health becomes increasingly prioritized worldwide.
The Future of Sigrid Therapeutics
Damir Konakovic, Head of Oral Health at Sigrid, emphasizes the importance of safety and efficacy in this field, stating that this collaboration will validate SiPore® through rigorous science. The goal is to develop products that not only meet scientific standards but also reach consumers effectively and efficiently.
About Sigrid Therapeutics
Sigrid Therapeutics was established with a mission to provide science-backed solutions for improving health. Through innovative partnerships and technologies, the company is poised to tackle significant health challenges and improve daily health routines for people everywhere.
Frequently Asked Questions
What is SiPore® technology?
SiPore® is a proprietary material technology platform designed to enhance oral health by binding and removing harmful proteins and enzymes.
Why is Sigrid collaborating with a multinational company?
This partnership aims to leverage resources and expertise to expand the use of SiPore® in consumer oral health effectively and sustainably.
What types of products will use SiPore®?
Products developed through this collaboration will primarily focus on oral health solutions, targeting plaque prevention and maintenance of overall dental hygiene.
How does SiPore® ensure safety in oral health?
SiPore® works mechanically, avoiding any systemic exposure, which enhances safety while providing effective oral care solutions.
What is Sigrid Therapeutics' vision for the future?
Sigrid aims to continue innovating in health solutions, developing products that are not only effective but also designed to meet global health demands.
